Alimera Sciences’ Acquisition of U.S. Commercial Rights to YUTIQ®

Leila Ahmed
Tagged:

Gunderson Dettmer represented Alimera Sciences on the transaction, while Sidley Austin LLP represented EyePoint Pharmaceuticals, Inc.Alimera Sciences, Inc. (Nasdaq: ALIM) (Alimera), a global pharmaceutical company, has announced…

This content is for Standard 1 Year members only.
Login Join Now
Avatar

Author: Leila Ahmed

…

This content is for Standard 1 Year members only.
Login Join Now